plasminogen activator protein-1
Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance
8
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
9
Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity
9
Key words
8
Targeted expression of plasminogen activator inhibitor(PAI)-1 to the stomach inhibits gut-brain signalling by the satiety hormone cholecystokinin (CCK)
236
Association of dietary soy with expression of various pro-inflammatory genes in porcine phagocytes
8
Regulation of urokinase plasminogen activator and plasminogen activator inhibitor-1 in murine breast cancer cells
140
The regulation of tissue plasminogen activator in rat brain glioma cells
212
Integrin dependent induction of functional urokinase receptors in primary T lymphocytes
10
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness
9
High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study
7
Coordinated induction of plasminogen activator inhibitor 1 (PAI 1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition
11
"Hypoxia induced down regulation of microRNA 449a/b impairs control over targeted SERPINE1 (PAI 1) mRNA a mechanism involved in SERPINE1 (PAI 1) overexpression"
14
Extracellular proteolysis in the adult murine brain
8
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
9
Thrombin induction of plasminogen activator inhibitor in cultured human endothelial cells
6
alpha Fucose mediated binding and degradation of tissue type plasminogen activator by HepG2 cells
9
Interaction between plasminogen activator inhibitor type 1 (PAI 1) bound to fibrin and either tissue type plasminogen activator (t PA) or urokinase type plasminogen activator (u PA) Binding of t PA/PAI 1 complexes to fibrin mediated by both the finger and the kringle 2 domain of t PA
10
Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
6
Structural and kinetic comparison of recombinant human single and two chain tissue plasminogen activator
8